VLC
CVS icon

Van Leeuwen & Company’s CVS Health CVS Stock Holding History

Van Leeuwen & Company’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-26,227
Closed -$1.72M – 78
2018
Q4 		$1.72M Buy
26,227
+4,027
+18% +$301K 1.72% 22
2018
Q3 		$1.75M Buy
+22,200
New +$1.59M 1.61% 25

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Van Leeuwen & Company's CVS Position: Q1 2019 in Review

Van Leeuwen & Company sold out of CVS Health (CVS) in Q1 2019, closing a stake of 26,227 shares — an estimated $1.72M sold.

Van Leeuwen & Company first reported a position in CVS in Q3 2018 and held it in 2 quarters. The position peaked at $1.75M in Q3 2018. 1,708 funds tracked by Wall St. Rank hold CVS as of Q1 2019.

  • Van Leeuwen & Company reported no remaining CVS Health position as of Q1 2019 after selling out during the quarter.
  • Van Leeuwen & Company sold 26,227 CVS Health shares in Q1 2019, an estimated $1.72M.
  • Van Leeuwen & Company first reported a position in CVS Health in Q3 2018 and held it in 2 quarters.
  • Van Leeuwen & Company's CVS Health position peaked at $1.75M in Q3 2018.
  • 1,708 funds tracked by Wall St. Rank held CVS Health as of Q1 2019.

Based on Van Leeuwen & Company's 13F filing for Q1 2019, filed 15 May 2019.